首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Design,synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitors
Authors:Min Jung Choi  Eun Joo Roh  Wooyoung Hur  So Ha Lee  Taebo Sim  Chang-Hyun Oh  Sun-Hwa Lee  Jong Seung Kim  Kyung Ho Yoo
Institution:1. Chemical Kinomics Research Center, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 02792, Republic of Korea;2. Center for Biomaterials, Korea Institute of Science and Technology, PO Box 131, Cheongryang, Seoul 02792, Republic of Korea;3. Efficacy Assessment Support Department, New Drug Development Center, 80 Chembok-ro Dong-gu, Daegu 41061, Republic of Korea;4. Department of Chemistry, Korea University, Seoul 02841, Republic of Korea
Abstract:A novel series of aminopyrimidinylisoindoline derivatives 1a-w having an aminopyrimidine scaffold as a hinge region binding motif were designed and synthesized. Among them, six compounds showed potent inhibitory activities against AXL kinase with IC50 values of submicromolar range. Especially, compound 1u possessing (4-acetylpiperazin-1-yl)phenyl moiety exhibited extremely excellent efficacy (IC50?=?<0.00050?μM). Their in vitro antiproliferative activities were tested over five cancer cell lines. Most compounds showed good antiproliferative activities against HeLa cell line. The kinase panel profiling of 50 different kinases and the selected inhibitory activities for the representative compound 1u were carried out. The compound 1u exhibited excellent inhibitory activities (IC50?=?<0.00050, 0.025, and 0.050?μM for AXL, MER, and TYRO3, respectively) against TAM family, together with potent antiproliferative activity against MV4-11 cell line (GI50?=?0.10?μM) related to acute myeloid leukemia (AML).
Keywords:Aminopyrimidinylisoindolines  Inhibitors  AXL kinase  TAM family  Enzyme inhibitory activity  Antiproliferative activity
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号